Frontline Chemoimmunotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Shows Superior Efficacy in Comparison to  Bendamustine (B) and Rituximab (BR) in Previously Untreated and Physically Fit Patients (pts) with Advanced Chronic Lymphocytic Leukemia (CLL): Final Analysis of an International, Randomized Study of the German CLL Study Group (GCLLSG) (CLL10 Study)

Barbara Eichhorst; Anna Maria Fink; Raymonde Busch; Gabor Kovacs; Christian Maurer; Elisabeth Lange; Hubert Köppler; Michael G Kiehl; Martin Soekler; Rudolf Schlag; Ursula Vehling-Kaiser; Georg R. A. Köchling; Christoph Plöger; Michael Gregor; Torben Plesner; Marek  Trneny; Kirsten  Fischer; Hartmut  Döhner; Michael Kneba; Clemens-Martin Wendtner; Wolfram Klapper; Karl Anton Kreuzer; Stephan Stilgenbauer; Sebastian Böttcher; Michael Hallek

Frontline Chemoimmunotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Shows Superior Efficacy in Comparison to Bendamustine (B) and Rituximab (BR) in Previously Untreated and Physically Fit Patients (pts) with Advanced Chronic Lymphocytic Leukemia (CLL): Final Analysis of an International, Randomized Study of the German CLL Study Group (GCLLSG) (CLL10 Study)

Barbara Eichhorst
, Anna Maria Fink
, Raymonde Busch
, Gabor Kovacs
, Christian Maurer
, Elisabeth Lange
, Hubert Köppler
, Michael G Kiehl
, Martin Soekler
, Rudolf Schlag
, Ursula Vehling-Kaiser
, Georg R. A. Köchling
, Christoph Plöger
, Michael Gregor
, Torben Plesner
, Marek Trneny
, Kirsten Fischer
, Hartmut Döhner
, Michael Kneba
, Clemens-Martin Wendtner

Wolfram Klapper, Karl Anton Kreuzer, Stephan Stilgenbauer, Sebastian Böttcher, Michael Hallek

Research output: Contribution to conference without publisher/journal › Conference abstract for conference › Research › peer-review

Original language	English
Publication date	2014
Publication status	Published - 2014
Event	56th American Society of Hematology Annual Meeting & Exposition - San Fransisco, CA, United States Duration: 6. Dec 2014 → 9. Dec 2014 Conference number: 56

Conference

Conference	56th American Society of Hematology Annual Meeting & Exposition
Number	56
Country/Territory	United States
City	San Fransisco, CA
Period	06/12/2014 → 09/12/2014

Documents & Links

https://ash.confex.com/ash/2014/webprogram/Paper69485.html

SDU Link

Check access to the material in SDU Library's search engine

Cite this

Eichhorst, B., Fink, A. M., Busch, R., Kovacs, G., Maurer, C., Lange, E., Köppler, H., G Kiehl, M., Soekler, M., Schlag, R., Vehling-Kaiser, U., R. A. Köchling, G., Plöger, C., Gregor, M., Plesner, T., Trneny, M., Fischer, K., Döhner, H., Kneba, M., ... Hallek, M. (2014). Frontline Chemoimmunotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Shows Superior Efficacy in Comparison to Bendamustine (B) and Rituximab (BR) in Previously Untreated and Physically Fit Patients (pts) with Advanced Chronic Lymphocytic Leukemia (CLL): Final Analysis of an International, Randomized Study of the German CLL Study Group (GCLLSG) (CLL10 Study). Abstract from 56th American Society of Hematology Annual Meeting & Exposition, San Fransisco, CA, United States. https://ash.confex.com/ash/2014/webprogram/Paper69485.html

Eichhorst, Barbara ; Fink, Anna Maria ; Busch, Raymonde et al. / Frontline Chemoimmunotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Shows Superior Efficacy in Comparison to Bendamustine (B) and Rituximab (BR) in Previously Untreated and Physically Fit Patients (pts) with Advanced Chronic Lymphocytic Leukemia (CLL) : Final Analysis of an International, Randomized Study of the German CLL Study Group (GCLLSG) (CLL10 Study). Abstract from 56th American Society of Hematology Annual Meeting & Exposition, San Fransisco, CA, United States.

@conference{3501c81adcf04a1b80b9956e8d01474e,

title = "Frontline Chemoimmunotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Shows Superior Efficacy in Comparison to Bendamustine (B) and Rituximab (BR) in Previously Untreated and Physically Fit Patients (pts) with Advanced Chronic Lymphocytic Leukemia (CLL): Final Analysis of an International, Randomized Study of the German CLL Study Group (GCLLSG) (CLL10 Study)",

author = "Barbara Eichhorst and Fink, \{Anna Maria\} and Raymonde Busch and Gabor Kovacs and Christian Maurer and Elisabeth Lange and Hubert K{\"o}ppler and \{G Kiehl\}, Michael and Martin Soekler and Rudolf Schlag and Ursula Vehling-Kaiser and \{R. A. K{\"o}chling\}, Georg and Christoph Pl{\"o}ger and Michael Gregor and Torben Plesner and Marek Trneny and Kirsten Fischer and Hartmut D{\"o}hner and Michael Kneba and Clemens-Martin Wendtner and Wolfram Klapper and Kreuzer, \{Karl Anton\} and Stephan Stilgenbauer and Sebastian B{\"o}ttcher and Michael Hallek",

year = "2014",

language = "English",

note = "56th American Society of Hematology Annual Meeting \& Exposition ; Conference date: 06-12-2014 Through 09-12-2014",

}

Eichhorst, B, Fink, AM, Busch, R, Kovacs, G, Maurer, C, Lange, E, Köppler, H, G Kiehl, M, Soekler, M, Schlag, R, Vehling-Kaiser, U, R. A. Köchling, G, Plöger, C, Gregor, M, Plesner, T, Trneny, M, Fischer, K, Döhner, H, Kneba, M, Wendtner, C-M, Klapper, W, Kreuzer, KA, Stilgenbauer, S, Böttcher, S & Hallek, M 2014, 'Frontline Chemoimmunotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Shows Superior Efficacy in Comparison to Bendamustine (B) and Rituximab (BR) in Previously Untreated and Physically Fit Patients (pts) with Advanced Chronic Lymphocytic Leukemia (CLL): Final Analysis of an International, Randomized Study of the German CLL Study Group (GCLLSG) (CLL10 Study)', 56th American Society of Hematology Annual Meeting & Exposition, San Fransisco, CA, United States, 06/12/2014 - 09/12/2014. <https://ash.confex.com/ash/2014/webprogram/Paper69485.html>

Frontline Chemoimmunotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Shows Superior Efficacy in Comparison to Bendamustine (B) and Rituximab (BR) in Previously Untreated and Physically Fit Patients (pts) with Advanced Chronic Lymphocytic Leukemia (CLL): Final Analysis of an International, Randomized Study of the German CLL Study Group (GCLLSG) (CLL10 Study). / Eichhorst, Barbara; Fink, Anna Maria; Busch, Raymonde et al.
2014. Abstract from 56th American Society of Hematology Annual Meeting & Exposition, San Fransisco, CA, United States.

Research output: Contribution to conference without publisher/journal › Conference abstract for conference › Research › peer-review

TY - ABST

T1 - Frontline Chemoimmunotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Shows Superior Efficacy in Comparison to Bendamustine (B) and Rituximab (BR) in Previously Untreated and Physically Fit Patients (pts) with Advanced Chronic Lymphocytic Leukemia (CLL)

T2 - 56th American Society of Hematology Annual Meeting & Exposition

AU - Eichhorst, Barbara

AU - Fink, Anna Maria

AU - Busch, Raymonde

AU - Kovacs, Gabor

AU - Maurer, Christian

AU - Lange, Elisabeth

AU - Köppler, Hubert

AU - G Kiehl, Michael

AU - Soekler, Martin

AU - Schlag, Rudolf

AU - Vehling-Kaiser, Ursula

AU - R. A. Köchling, Georg

AU - Plöger, Christoph

AU - Gregor, Michael

AU - Plesner, Torben

AU - Trneny, Marek

AU - Fischer, Kirsten

AU - Döhner, Hartmut

AU - Kneba, Michael

AU - Wendtner, Clemens-Martin

AU - Klapper, Wolfram

AU - Kreuzer, Karl Anton

AU - Stilgenbauer, Stephan

AU - Böttcher, Sebastian

AU - Hallek, Michael

N1 - Conference code: 56

PY - 2014

Y1 - 2014

M3 - Conference abstract for conference

Y2 - 6 December 2014 through 9 December 2014

ER -

Eichhorst B, Fink AM, Busch R, Kovacs G, Maurer C, Lange E et al.. Frontline Chemoimmunotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Shows Superior Efficacy in Comparison to Bendamustine (B) and Rituximab (BR) in Previously Untreated and Physically Fit Patients (pts) with Advanced Chronic Lymphocytic Leukemia (CLL): Final Analysis of an International, Randomized Study of the German CLL Study Group (GCLLSG) (CLL10 Study). 2014. Abstract from 56th American Society of Hematology Annual Meeting & Exposition, San Fransisco, CA, United States.